Watchdog considers $1.6 billion merger of pathology testing companies
![](https://www.ausdoc.com.au/wp-content/uploads/2023/06/iStock-1171660014-pathology-testing-microscope-300x225.jpg)
The RACGP is urging the national consumer watchdog to stop Australian Clinical Labs taking over Healius Pathology, on the grounds a pathology testing supergroup would harm GP practices with co-located collection centres.
The college made the plea to the ACCC, which is investigating the impact on bulk-billing and prices if Australian Clinical Labs is allowed to purchase all Healius shares.